SCHEMBL9803206

SCHEMBL9803206

CCN(C(=O)C(=O)O)N(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.32
PHF8 Q9UPP1 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2465652 0.78
SCHEMBL1903711 0.75 TDP1 (0.32)
Hydrochloric Acid SCHEMBL3866987 0.73 TDP1 (0.31)
SCHEMBL209469 0.72
SCHEMBL7106599 0.72
SCHEMBL5474525 0.70
SCHEMBL13678663 0.70 LMNA (0.35) FFAR3PHF8KDM2A
SCHEMBL8893409 0.70
SCHEMBL11291649 0.70
SCHEMBL52110 0.69 LMNA (0.43) FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066677-A Antihypoxic agents, treatment of disorders resulting from reduced oxygen supply to brain MEIJI SEIKA KAISHA, LTD. (JP) 1991-11-19 US disclosed